101 Combinatorial cancer therapy using a pharmacological inhibitor of indoleamine 2,3-dioxygenase (IDO), a target of the cancer suppression gene Bin1
A.J. Muller, J.B. DuHadaway, E. Sutanto-Ward, P.S. Donover, G.C. PrendergastVolume:
2
Year:
2004
Language:
english
DOI:
10.1016/s1359-6349(04)80109-5
File:
PDF, 145 KB
english, 2004